Insomnia and Sleep Problems: A Care Staff Guide to Safe Support

Poor sleep is one of the most common complaints in care homes, hospitals and community services, and one of the easiest to treat badly. A sleeping tablet is quick to prescribe and quick to take, but it can bring daytime drowsiness, falls and dependence, and it does not address why the person cannot sleep. This guide explains what current UK guidance says about managing insomnia, what care staff can do, and when a sleep problem needs a clinician. It is general information, not clinical advice.

What counts as insomnia

Insomnia means difficulty falling asleep, staying asleep or waking too early, together with daytime effects such as tiredness, poor concentration, low mood or irritability. Short-term insomnia often follows a stressful event, illness, pain or a change of environment. Chronic insomnia lasts for weeks or months and often needs a different approach. Sleep problems are also closely tied to mental health: poor sleep can worsen anxiety and depression, and those conditions can in turn disrupt sleep. See our guide to depression screening for older adults in care homes.

Start with the basics: sleep hygiene and the environment

NHS Greater Glasgow and Clyde's guideline on managing insomnia puts sleep hygiene first. Its advice includes keeping regular sleep and wake times, avoiding naps, avoiding backlit screens for an hour before bed, keeping the bedroom dark, quiet and cool, limiting caffeine, alcohol and tobacco (especially after midday), taking regular exercise but not in the 3 to 4 hours before bedtime, and getting daily natural light. In care settings, staff can apply the same ideas: reduce night-time noise and light, avoid unnecessary night checks that wake sleeping residents, check that pain, thirst, hunger, continence needs and room temperature are not the cause, and keep daytime activity and sunlight exposure up.

CBT for insomnia comes before tablets

Cognitive behavioural therapy for insomnia (CBT-I) is generally regarded as the first-line treatment for chronic insomnia. US Department of Veterans Affairs and Department of Defense guidance advises offering CBT-I first and not relying on sleep hygiene education alone. NICE's supporting material points to digital CBT-I programmes such as Sleepio as a self-directed option. CBT-I tackles sleep scheduling, the mental arousal that keeps people awake and unhelpful beliefs about sleep. The early stages can feel harder before they get better, so staff who support someone through it should expect and recognise that.

Sleeping tablets: short-term only

NICE's technology appraisal guidance says that the short-acting medicines zaleplon, zolpidem and zopiclone, commonly called Z-drugs, are for short-term relief. NHS Greater Glasgow and Clyde's guideline sets the limits plainly: prescriptions should be for short-term use of no more than four weeks, with regular reviews, using the lowest effective dose and intermittent dosing such as alternate nights where possible. For melatonin, it gives a maximum treatment duration of 13 weeks. The same guideline lists daytime sedation, poor coordination, impaired thinking and an increased risk of driving accidents and falls, especially in older people. It advises discontinuing slowly to reduce rebound insomnia and withdrawal symptoms.

The key message for staff is that a sleeping tablet that has been given every night for months is a review trigger, not a routine. Raise it with the prescriber, and check it against your medicines policy. Our guide to falls prevention under CQC Regulation 12 explains why sedating medicines belong in the falls risk assessment, and the STOMP guide to overmedication shows how long-term psychotropic medicines in people with a learning disability or autism are reviewed.

Who needs extra caution

The VA/DoD guidance advises extra care with medicines for older adults, pregnant people and anyone with falls, cognitive impairment, respiratory disease, liver disease or a history of substance misuse. It also says that medicine, if used, should be an individual, time-limited, shared decision that is reviewed rather than renewed automatically. In practice, staff supporting older residents should ask each time whether a sleeping tablet is still needed, whether non-drug approaches have been tried, and whether alcohol or other sedatives are also in use.

Red flags: when sleep problems are not just insomnia

• Loud snoring, gasping or pauses in breathing at night, with severe daytime sleepiness, can indicate obstructive sleep apnoea and needs assessment.
• Unusual movements or behaviours during sleep may be a parasomnia or movement disorder.
• Dangerous sleepiness, such as falling asleep while eating or driving, needs prompt escalation.
• New insomnia with low mood, hopelessness or confusion may signal depression or delirium and should be reported straight away.

Frequently asked questions

Can staff give a sleeping tablet that is prescribed as needed?

Only in line with the prescription, the person's capacity and consent, and your medicines policy. Record the reason, and flag frequent use to the prescriber.

Is melatonin the same as a Z-drug?

No. They are different medicines with different risks and licensing, and guidance sets separate maximum durations. The prescriber should explain which is being used and why.

What training supports this?

Medicines safety, falls prevention and mental health awareness are all relevant. Browse the Learnsignal CPD hub for healthcare compliance courses.

Sources: NHS Greater Glasgow and Clyde, Management of insomnia guideline; NICE technology appraisal guidance on zaleplon, zolpidem and zopiclone; US VA/DoD guideline on chronic insomnia and obstructive sleep apnoea (2025). This article is general information, not clinical advice.